Prognostic value of single nodal zone metastasis in non-small-cell lung cancer

European Journal of Cardio-thoracic Surgery

Volumn 38, Issue 4, 2010, Pages 491-497

  Kim, Moon Soo ^a   Lee, Hyun Sung ^a   Lee, Jong Mog ^a   Zo, Jae Ill ^a   Lee, Geon Kook ^a   Nam, Byung Ho ^a  

^a National Cancer Center   (South Korea)

Author keywords

Lung cancer; Lymph node; Surgery

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONFIDENCE INTERVAL; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURGICAL MORTALITY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MEDIASTINUM; MIDDLE AGED; NEOPLASM STAGING; PNEUMONECTOMY; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RECURRENCE; TREATMENT OUTCOME;

EID: 77957265162     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2010.02.033     Document Type: Article

References (25)

1. Friedel G., Steger V., Kyriss T., Zoller J., Toomes H. Prognosis in N2 NSCLC. Lung Cancer 2004, 45(Suppl. 2):S45-S53.
2. Roth J.A., Fossella F., Komaki R., Ryan M.B., Putnam J.B., Lee J.S., Dhingra H., De Caro L., Chasen M., McGavran M., Atkinson E.N., Hong W.K. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst 1994, 86:673-680.
3. Rosell R., Gomez-Codina J., Camps C., Maestre J., Padille J., Canto A., Mate J.L., Li S., Roig J., Olazabal A., Canela M., Ariza A., Skacel Z., Morera-Prat J., Abad A. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med 1994, 330:153-158.
4. Vansteenkiste J., Betticher D., Eberhardt W., De Leyn P. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer. J Thorac Oncol 2007, 2:684-685.
5. Belvedere O., Grossi F. Lung cancer highlights from ASCO 2005. Oncologist 2006, 11:39-50.
6. Robinson L.A., Ruckdeschel J.C., Wagner H., Stevens C.W. Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007, 132:243S-265S.
7. Ettinger D.S., Akerley W., Bepler G., Chang A., Cheney R.T., Chirieac L.R., D'Amico T.A., Demmy T.L., Feigenberg S.J., Figlin R.A., Govindan R., Grannis F.W., Jahan T., Jahanzeb M., Kessinger A., Komaki R., Kris M.G., Langer C.J., Le Q.T., Martins R., Otterson G.A., Patel J.D., Robert F., Sugarbaker D.J., Wood D.E. Non-small cell lung cancer. J Natl Compr Canc Netw 2008, 6:228-269.
8. Patterson G.A., Piazza D., Pearson F.G., Todd T.R., Ginsberg R.J., Goldberg M., Waters P., Jones D., Ilves R., Cooper J.D. Significance of metastatic disease in subaortic lymph nodes. Ann Thorac Surg 1987, 43:155-159.
9. Ichinose Y., Kato H., Koike T., Tsuchiya R., Fujisawa T., Shimizu N., Watanabe Y., Mitsudomi T., Yoshimura M., Tsuboi M. Completely resected stage IIIA non-small cell lung cancer: the significance of primary tumor location and N2 station. J Thorac Cardiovasc Surg 2001, 122:803-808.
10. Inoue M., Sawabata N., Takeda S., Ohta M., Ohno Y., Maeda H. Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe. J Thorac Cardiovasc Surg 2004, 127:1100-1106.
11. Kang C.H., Ra Y.J., Kim Y.T., Jheon S.H., Sung S.W., Kim J.H. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer. Ann Thorac Surg 2008, 86:1092-1097.
12. Lee J.G., Lee C.Y., Park I.K., Kim D.J., Park S.Y., Kim K.D., Chung K.Y. Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival. Ann Thorac Surg 2008, 85:211-215.
13. Rusch V.W., Crowley J., Giroux D.J., Goldstraw P., Im J.G., Tsuboi M., Tsuchiya R., Vansteenkiste J. The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2007, 2:603-612.
14. Rusch V.W., Asamura H., Watanabe H., Giroux D.J., Rami-Porta R., Goldstraw P. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2009, 4:568-577.
15. Mountain C.F., Dresler C.M. Regional lymph node classification for lung cancer staging. Chest 1997, 111:1718-1723.
16. Casali C., Stefani A., Natali P., Rossi G., Morandi U. Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases. Eur J Cardiothorac Surg 2005, 28:33-38.
17. Misthos P., Sepsas E., Kokotsakis J., Skottis I., Lioulias A. The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer. Ann Thorac Surg 2008, 86:1626-1630.
18. Cerfolio R.J., Bryant A.S. Survival of patients with unsuspected N2 (stage IIIA) nonsmall-cell lung cancer. Ann Thorac Surg 2008, 86:362-366. [Discussion 366-367].
19. Ohta Y., Shimizu Y., Minato H., Matsumoto I., Oda M., Watanabe G. Results of initial operations in non-small cell lung cancer patients with single-level N2 disease. Ann Thorac Surg 2006, 81:427-433.
20. Watanabe S., Ladas G., Goldstraw P. Inter-observer variability in systematic nodal dissection: comparison of European and Japanese nodal designation. Ann Thorac Surg 2002, 73:245-248. [Discussion 248-249].
21. Naruke T., Suemasu K., Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 1978, 76:832-839.
22. Arriagada R., Bergman B., Dunant A., Le Chevalier T., Pignon J.P., Vansteenkiste J. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004, 350:351-360.
23. Okada M., Tsubota N., Yoshimura M., Miyamoto Y., Matsuoka H. Prognosis of completely resected pN2 non-small cell lung carcinomas: what is the significant node that affects survival?. J Thorac Cardiovasc Surg 1999, 118:270-275.
24. Goldstraw P., Mannam G.C., Kaplan D.K., Michail P. Surgical management of non-small-cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease). J Thorac Cardiovasc Surg 1994, 107:19-27. [Discussion 27-18].
25. Vansteenkiste J.F., De Leyn P.R., Deneffe G.J., Stalpaert G., Nackaerts K.L., Lerut T.E., Demedts M.G. Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases. Leuven Lung Cancer Group. Ann Thorac Surg 1997, 63:1441-1450.